Nitrofurantoïne Mc Viatris (Nitrofurantoin)

Nitrofurantoin is reduced by bacterial enzymes to reactive intermediates that damage bacterial DNA, ribosomal proteins, and carbohydrate‑metabolizing enzymes. This multi‑targeted attack disrupts essential bacterial processes, resulting in either bacteriostatic or bactericidal activity against organisms that cause urinary tract infections.

The dosage of Nitrofurantoïne Mc Viatris is determined by the prescribing healthcare professional based on the severity of the infection, the patient’s renal function, and other clinical factors. Patients should follow the exact regimen prescribed by their doctor and not adjust the dose on their own.

Safety data for nitrofurantoin in pregnancy are limited, and the drug is generally avoided near term because of potential fetal hemolysis. It is excreted in breast milk in small amounts, so a risk‑benefit assessment by a physician is required. Pregnant or nursing women should discuss alternatives with their healthcare provider.

To request Nitrofurantoïne Mc Viatris, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any required temperature control), and import documentation.

Nitrofurantoin offers a narrow spectrum focused on urinary pathogens and achieves high urinary concentrations, making it effective for uncomplicated cystitis. Compared with broader agents such as trimethoprim‑sulfamethoxazole, nitrofurantoin has a lower risk of promoting systemic resistance but is unsuitable for patients with reduced renal function. Choice of therapy depends on local resistance patterns and patient-specific factors.

Store Nitrofurantoïne Mc Viatris at ambient temperature, below 25 °C, in the original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments, which could affect tablet integrity.

Nitrofurantoïne Mc Viatris is taken orally with a full glass of water. It can be taken with food or milk to lessen gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it, unless otherwise directed by a healthcare professional.

Serious adverse reactions include pulmonary toxicity (interstitial pneumonitis or fibrosis), hepatic injury, severe allergic responses such as anaphylaxis or Stevens‑Johnson syndrome, hemolytic anemia (especially in G6PD‑deficient individuals), and peripheral neuropathy. Any signs of respiratory distress, liver dysfunction, skin rash, or unexplained anemia warrant immediate medical evaluation.

Nitrofurantoïne Mc Viatris should be avoided in patients with severe renal impairment (eGFR <30 mL/min), known hypersensitivity to nitrofurantoin or other nitrofurans, pregnant women in the later stages of pregnancy, and individuals with a history of pulmonary, hepatic, or severe allergic reactions to the drug. Clinicians must assess each patient’s medical history before prescribing.